The need for an evidence-based decision-making process with regard to control of hepatitis A

Journal of Viral Hepatitis

Volumn 15, Issue SUPPL.2, 2008, Pages 16-21

  Gentile, A ^a,b  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b NONE   (Argentina)

Author keywords

Hepatitis A control; Hepatitis A vaccination; Onedose schedule

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ARGENTINA; CLINICAL DECISION MAKING; CONFERENCE PAPER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; EPIDEMIC; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH PROGRAM; HEPATITIS A; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; LIVER FAILURE; POLITICS; PREVALENCE; PRIORITY JOURNAL; SANITATION; SEROPREVALENCE; SINGLE DRUG DOSE; SOCIAL ASPECT; SOUTH AND CENTRAL AMERICA; TREATMENT OUTCOME; VACCINATION;

DECISION MAKING; EVIDENCE-BASED PRACTICE; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; LATIN AMERICA; PREVALENCE;

EID: 50649110293     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01023.x     Document Type: Conference Paper

References (23)

1. Tanno H, Fay OH, Rojman JA, Palazzi J. Biphasic form of hepatitis A virus infection: a frequent variant in Argentina. Liver 1988 8 : 53 57.
2. Stapleton JT, Lemon SM. Hepatitis A and E. In : Hoeprich P, Jordan MC, Roland AR, eds. Infection Diseases, 5th edn. Philadelphia, PA, USA, Lippincott Co., 1994 : 790 800.
3. WHO. Hepatitis A vaccines. Wkly Epidemiol Rec 2000 5 : 38 44.
4. Argentina, Ministerio de Salud y Ambiente. Resolución 653/05. Boletín Oficial de la República Argentina. 113(30677). Argentina : Buenos Aires, 2005.
5. Argentina, Ministerio de Salud y Ambiente, Boletín Epidemiológico periódico Hepatitis A, documento técnico. Año 3, abril 2005, Buenos Aires. http://www.msal.gov.ar/htm/Site/ sala_situacion/PANELES/boletines/boletin_especial_HAV2.pdf (accessed 14 July 2008)
6. Van Damme P, Van Herck K. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine. Expert Rev Vaccines 2004 3 : 249 267.
7. Villar LM, Lampe E, Meyer A, Gaspar AMC. Genetic variability of hepatitis A virus isolates in Rio de Janeiro: implications for the vaccination of school children. Braz J Med Biol Res 2004 37 : 1779 1787.
8. Kumate J, Alvizouri AM, Isibasi A. Serologic survey of hepatitis A antibodies in Mexican children. Bull Pan Am Health Organ 1982 16 : 156 160.
9. Gonzalez J, Fay O, Cañero-Velasco C et al. Infección por virus de hepatitis A (HVA) en niños en Argentina. Ensayo piloto. Acta Gastroenterol Latinoam 1997 27 : 331 334.
10. Gentile A, Badía I, Galoppo C et al. Multicenter Study of IgG Hepatitis A Prevalence. 7th European Congress of Clinical Microbiology and Infectious Diseases. Poster Presentation, Lausanne, Switzerland, 1997.
11. Tapia-Conyer R, Santos JL, Cavalcanti AM et al. Hepatitis A in Latin America: a changing epidemiologic pattern. AM J Trop Med Hyg 1999 61 : 825 829.
12. th ICAAC, Toronto, ON, Canada, 1997.
13. Ciocca ME, Ramonet MD, Cuarterolo ML et al. Acute liver failure in children: experience with 210 patients. J Pediatr Gastroenterol Nutr 2004 39 (Suppl. 1 S31.
14. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993 342 : 273 275.
15. Lopez E, Debbag R, Coudeville L, Baron-Papillon F, Armoni J. The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis. J Gastroenterology 2007 42 : 152 160.
16. Ellis A, Ruttimann R, Jacobs J, Meyerhoff A, Innis B. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted. Rev Panam Salud Pública 2007 21 : 345 356.
17. Innis BL, Snibthan R, Kunasol P et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994 271 : 1328 1334.
18. Lemon SM. Inactivated hepatitis A vaccines. JAMA 1994 271 : 1363 1364.
19. Werzberger A, Mensch B, Kuter B et al. Controlled trial of a formalin inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992 327 : 453 457.
20. Beck BR, Hatz C, Bronnimann R, Herzog C. Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine. Clin Infect Dis 2003 37 : 126 128.
21. Van Damme P, Banatvala J, Fay O et al. Hepatitis A booster vaccination: is there a need? Lancet 2003 362 : 1065 1071.
22. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005 294 : 202 210.
23. WHO. Vaccine Introduction Guidelines. Adding a Vaccine to a National Immunization Programme: Decision and Implementation. 2005. WHO/IVB/05.18. http://www.who.int/vaccines-documents (accessed 15 July 2008)